Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antony H. Goldstone, FRCP
University College London Hospitals
Study Chair - Jacob M. Rowe, MD
Rambam Health Care Campus
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Evanston Northwestern Healthcare - Evanston Hospital
Evanston, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Methodist Cancer Center at Methodist Hospital
Indianapolis, Indiana, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Cedar Rapids Oncology Associates
Cedar Rapids, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Tufts-Nemc Cancer Center
Boston, Massachusetts, United States
- Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Genesys Hurley Cancer Institute
Flint, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, United States
- Foote Hospital
Jackson, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 1993
- Primary completion
- 31 Dec 2006
- Completion
- —
- Last update posted
- 18 Jun 2023
- Registered enrollment
- 1,929
- Registry id
- NCT00002514
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.